ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Researchers Trying to Zero In on Nasal Polyps Find Target Elusive

by Thomas R. Collins • October 1, 2009

  • Tweet
  • Email
Print-Friendly Version

He said that treatment for eicosanoid imbalance might be worthwhile even in a wide range of patients. The question is: Is this really something to use even in aspirin-tolerant patients? I think yes. I think the eicosonoid metabolism is certainly a parameter that is relevant also in polypous chronic rhinosinusitis, where you do not see a clinical impact of aspirin sensitivity, he said. And, as we have learned from all this interest we have in aspirin sensitization, there is effective treatment in hand and therefore it is worthwhile evaluating this as a therapeutic target also in those patients.

You Might Also Like

  • Steroid-Eluting Implants Effective for Recurrent Nasal Polyps
  • Scant Data on Oral Corticosteroid Therapy for CRS Without Polyps
  • Researchers Find Evidence of Esophageal-Nasal Reflex
  • Pre-Operative Steroid Use Beneficial Preceding Nasal Polyposis Surgery
Explore This Issue
October 2009

Corticosteroid Treatment

Dr. Cervin said that corticosteroids still sit at the top of the heap when it comes to treating nasal polyps. It’s the old steroids that are still the mainstay in our treatment, combined with nasal douche.

The goals of treatment for nasal polyposis include establishing nasal patency, reducing runny nose, improving the sense of smell, delaying or slowing the growth of polyps, helping with or delaying surgery, and reducing the number of infections.

Glucocorticoids work by reducing vasodilation, reducing recruitment of inflammatory cells, reducing MMP-9 that breaks down the extracellular matrix, and reducing IgE production.

The differences between different intranasal corticosteroids appear limited and safety differences have been described as more theoretical than based on clinical observation, he said.

A 2008 study (Derendorf H et al. Allergy 2008;63:1292-1300) found that absorption into the system was similar for many types of the drugs. The biovailability of flunisolide was 50%, whereas it was just less than 50% for triamcinolone and beclomethasone. The bioavailability for budesonide was about 35%, the study found.

Clinical trials that evaluated the effects of intranasal corticosteroids on HPA axis function and growth in children found that they generally do not affect growth (Moller C et al. Clin Exp Allergy 2003;33: 816-22; Skoner DP et al. Ann Allergy Asthma Immunol 2003;90:56-62). One early study (Wolthers OD et al. Acta Paediatri 1993;82:635-40), though, found that they caused slower growth of the lower leg.

Studies have found that a twice-a-day dose of mometasone furoate nasal spray (MFNS) is better than once-a-day. Patients getting 200 mcg of MFNS have reported significantly better symptom relief than those on a placebo. The improvements included better breathing, less interference with daily activities, and less disturbance of sleep (Stjarne P et al. Acta Otolaryngol 2006; 132:179-85). But there was no significant difference between the groups when it came to taste and smell improvements.

Pages: 1 2 3 4 5 6 7 8 9 | Single Page

Filed Under: Head and Neck, Medical Education, Rhinology Tagged With: autoimmune, head and neck surgery, Nasal polyposis, research, staphylococcus, treatmentIssue: October 2009

You Might Also Like:

  • Steroid-Eluting Implants Effective for Recurrent Nasal Polyps
  • Scant Data on Oral Corticosteroid Therapy for CRS Without Polyps
  • Researchers Find Evidence of Esophageal-Nasal Reflex
  • Pre-Operative Steroid Use Beneficial Preceding Nasal Polyposis Surgery

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Weaning Patients Off of PPIs
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Vertigo in the Elderly: What Does It Mean?
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Podcasts Becoming More Popular Method of Education for Otolaryngologists
    • How to Embrace Optimism in the Midst of the COVID-19 Pandemic
    • Tips on How to Approach Conversations with Patients about the COVID-19 Vaccine
    • Steps You Should Take to Protect Your Voice and Hearing During Telemedicine Sessions
    • Routine Postoperative Adjunct Treatments Unnecessary for Idiopathic Cerebrospinal Fluid Leaks

Polls

Have you spoken with your patients about receiving the COVID-19 vaccine?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.